Oplinc|Special Report on Orphan Drugs

Orphan drugs are pharmaceutical agents developed specifically to treat a rare medical condition. In the United States, an orphan drug is defined as a drug that treats a disease that affects less than 200,000 individuals, or less than 5 per 10,000 people in a community. Orphan drug status is becoming more common due to research efforts in oncology. Orphan drugs are developed in response to public health need.

No comments have been posted yet.